A single stretch of DNA with no label or known origin may look like a random jumble of letters. Yet for scientists, that sequence could be the key to understanding inherited disease, drug response, or the next breakthrough in personalized medicine. Using a widely available search tool called BLAST, researchers can now identify unknown genes in seconds and reveal their role in human health.
Developed by the National Center for Biotechnology Information, BLAST compares an unknown DNA sequence against millions of known genetic sequences stored in a global database. The software returns key measurements that help researchers judge the match: percent identity shows how similar two sequences are, query coverage indicates how much of the sequence aligns with a known gene, and the E-value estimates the probability that the match happened by chance. Together, these metrics allow scientists to identify genes with remarkable confidence without months of lab work.
In a recent bioinformatics exercise, two mystery sequences were analyzed using BLAST. The first matched the hemoglobin beta (HBB) gene, which produces a protein essential for carrying oxygen from the lungs to tissues throughout the body. Mutations in this gene cause inherited disorders such as sickle cell disease and beta-thalassemia, conditions that affect millions of people worldwide. The second sequence belonged to the cytochrome P450 (CYP) gene family, often called the body’s natural chemical processing system. Located mainly in the liver, these enzymes break down medications, toxins, and other compounds. Genetic differences in CYP genes help explain why a drug works well for one patient but causes side effects or fails in another, making these genes increasingly important for designing safer, more personalized treatments.
The project also examined gene conservation, comparing human DNA sequences with those of chimpanzees, gorillas, and crab eating macaques. Humans and chimpanzees share approximately 98 to 99 percent of their DNA, and genes responsible for fundamental biological functions often change very little over millions of years of evolution. This conservation allows researchers to study diseases and test potential treatments in animals such as mice or zebrafish, with greater confidence that the findings will translate to human therapies.
What makes this technology especially promising is its accessibility. Students and researchers worldwide can use the same BLAST software with only an internet connection and a DNA sequence. As bioinformatics continues to transform biology into a data driven science, the ability to decode life’s genetic instructions quickly and accurately is opening new doors for understanding disease and developing targeted treatments.